TapewireFind a company

person · Reporting owner

Leonard Keith R

Disclosed activity across 4 companies

Tapewire entity
14730
SEC CIK
0001416180

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Arcutis Biotherapeutics, Inc.ARQT · Entity 4236DirectorJune 05, 2026June 10, 2026
INTUITIVE SURGICAL INCISRG · Entity 2878DirectorApril 30, 2026May 01, 2026
Sienna Biopharmaceuticals, Inc.SNNA · Entity 154554DirectorMay 30, 2019June 03, 2019
Unity Biotechnology, Inc.UBX · Entity 77428DirectorJune 21, 2024June 21, 2024

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Arcutis Biotherapeutics, Inc.

Report date June 05, 2026 · Filed June 10, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect27,901 Reported balance After 2026-06-05 transaction · row 1
1 source row

Row 1 · 2026-06-05 · Grant · Acquired 5,778 · Balance 27,901

F1: Represents Restricted Stock Units ("RSUs") granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof, which shall occur on the earlier of the first anniversary of the grant date, June 5, 2026, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date. Upon vesting of the RSUs, the settlement has been deferred by the Reporting Person, pursuant to the terms of the RSU Deferral Election Form adopted on October 28, 2025, maintained by the Company.

Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $21.23 · Expires 2036-06-05Direct16,667 Reported balance After 2026-06-05 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2026-06-05 · Grant · Acquired 16,667 · Balance 16,667

F3: The underlying shares subject to the option vest and become exercisable as to 100% on the earlier of the first anniversary of the grant date, June 5, 2026, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date.

Common StockSEC Table I · non-derivativeIndirectBy Leonard Family Trust dated August 28, 19961,750 Reported balance Holding disclosure · report date 2026-06-05 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 1,750

F2: Shares held by Leonard Family Trust dated August 28, 1996, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.

Filing footnotes · ownership attribution and instrument terms

F1: Represents Restricted Stock Units ("RSUs") granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof, which shall occur on the earlier of the first anniversary of the grant date, June 5, 2026, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date. Upon vesting of the RSUs, the settlement has been deferred by the Reporting Person, pursuant to the terms of the RSU Deferral Election Form adopted on October 28, 2025, maintained by the Company.

F2: Shares held by Leonard Family Trust dated August 28, 1996, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.

F3: The underlying shares subject to the option vest and become exercisable as to 100% on the earlier of the first anniversary of the grant date, June 5, 2026, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date.

INTUITIVE SURGICAL INC

Report date April 30, 2026 · Filed May 01, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect901 Reported balance After 2026-04-30 transaction · row 1
1 source row

Row 1 · 2026-04-30 · Exercise / conversion · Acquired 531 · Balance 901

Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00Direct0 Reported balance After 2026-04-30 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2026-04-30 · Exercise / conversion · Disposed 531 · Balance 0

F1: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service.

Restricted Stock Units - 4-30-2026SEC Table II · derivative / convertible security · Conversion / exercise price $0.00Direct554 Reported balance After 2026-04-30 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2026-04-30 · Grant · Acquired 554 · Balance 554

F1: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service.

Filing footnotes · ownership attribution and instrument terms

F1: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service.

Sienna Biopharmaceuticals, Inc.

Report date May 30, 2019 · Filed June 03, 2019

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Stock Options (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.22 · Expires 2029-05-30Direct25,000 Reported balance After 2019-05-30 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2019-05-30 · Grant · Acquired 25,000 · Balance 25,000

F1: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, subject to continued service through each applicable vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, subject to continued service through each applicable vesting date.

Unity Biotechnology, Inc.

Report date June 21, 2024 · Filed June 21, 2024

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.38 · Expires 2034-06-20Direct10,000 Reported balance After 2024-06-21 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2024-06-21 · Grant · Acquired 10,000 · Balance 10,000

F1: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the one-year anniversary measured from June 21, 2024 or (ii) the date of the 2025 Annual Meeting of the Issuer's stockholders, assuming continuous service as a Director until such vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the one-year anniversary measured from June 21, 2024 or (ii) the date of the 2025 Annual Meeting of the Issuer's stockholders, assuming continuous service as a Director until such vesting date.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 18, 2020 Filed Jun 22, 2020 17:23 UTC Unity Biotechnology, Inc. UBX · Entity 77428 GrantStock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $9.14 $0.00
Disclosure

SEC source: 0000899243-20-017383 · doc4.xml · derivative · entry 1

Leonard Keith R · CIK 0001416180 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2030-06-17

F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable with respect to 1/36th of the total number of shares subject to the option in successive, equal monthly installments measured from June 18, 2020, subject to the Reporting Person's continued service relationship with the Issuer on each vesting date.

Read SEC document
April 23, 2020 Filed Apr 27, 2020 20:01 UTC INTUITIVE SURGICAL INC ISRG · Entity 2878 GrantNon-Qualified Stock Option (right to buy) · Derivative 766 $0.00 Strike: $513.22 $0.00
Disclosure

SEC source: 0001567619-20-008487 · doc1.xml · derivative · entry 4

Leonard Keith R · CIK 0001416180 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 766

Underlying: Common Stock · 766 shares

Expires 2030-04-23

F4 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one year anniversary of April 23, 2020 or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service as a director to the issuer.

Read SEC document
April 23, 2020 Filed Apr 27, 2020 20:01 UTC INTUITIVE SURGICAL INC ISRG · Entity 2878 GrantRestricted Stock Units · Derivative 255 $0.00 $0.00
Disclosure

SEC source: 0001567619-20-008487 · doc1.xml · derivative · entry 3

Leonard Keith R · CIK 0001416180 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 255

Underlying: Common Stock · 255 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis upon vesting.

F3 · derivative.exercise_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of April 23, 2020 or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service as a director to the issuer.

F3 · derivative.expiration_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of April 23, 2020 or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service as a director to the issuer.

Read SEC document
April 23, 2020 Filed Apr 27, 2020 20:01 UTC INTUITIVE SURGICAL INC ISRG · Entity 2878 Exercise / conversionRestricted Stock Units · Derivative 262 $0.00 $0.00
Disclosure

SEC source: 0001567619-20-008487 · doc1.xml · derivative · entry 2

Leonard Keith R · CIK 0001416180 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 262 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis upon vesting.

F2 · derivative.exercise_date: On April 25, 2019, the Reporting Person was granted 262 RSUs, vesting as to 100% on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders.

F2 · derivative.expiration_date: On April 25, 2019, the Reporting Person was granted 262 RSUs, vesting as to 100% on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders.

Read SEC document
April 23, 2020 Filed Apr 27, 2020 20:01 UTC INTUITIVE SURGICAL INC ISRG · Entity 2878 Exercise / conversionCommon Stock 262 Not disclosed Not disclosed
Disclosure

SEC source: 0001567619-20-008487 · doc1.xml · nonDerivative · entry 1

Leonard Keith R · CIK 0001416180 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 594

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis upon vesting.

Read SEC document
February 13, 2020 Filed Feb 14, 2020 01:44 UTC INTUITIVE SURGICAL INC ISRG · Entity 2878 Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 1,545 $0.00 Strike: $271.48 $0.00
Disclosure

SEC source: 0001035267-20-000034 · edgardoc.xml · derivative · entry 3

Leonard Keith R · CIK 0001416180 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,545 shares

Expires 2027-04-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on October 30, 2020.

F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant or at the next Shareholders Meeting, whichever should take place first, provided that vesting will cease on termination of the Directors service to the Company.

Read SEC document
February 13, 2020 Filed Feb 14, 2020 01:44 UTC INTUITIVE SURGICAL INC ISRG · Entity 2878 SaleCommon Stock 1,545 $600.00 $927,000.00
Disclosure

SEC source: 0001035267-20-000034 · edgardoc.xml · nonDerivative · entry 2

Leonard Keith R · CIK 0001416180 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 332

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on October 30, 2020.

Read SEC document
February 13, 2020 Filed Feb 14, 2020 01:44 UTC INTUITIVE SURGICAL INC ISRG · Entity 2878 Exercise / conversionCommon Stock 1,545 $271.48 $419,441.70
Disclosure

SEC source: 0001035267-20-000034 · edgardoc.xml · nonDerivative · entry 1

Leonard Keith R · CIK 0001416180 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,877

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on October 30, 2020.

Read SEC document
December 27, 2019 Filed Feb 12, 2020 17:21 UTC Unity Biotechnology, Inc. UBX · Entity 77428 GiftCommon Stock, $0.0001 par value 500,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-004324 · doc5.xml · nonDerivative · entry 3

Leonard Keith R · CIK 0001416180 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 500,000

F3 · ownership.nature: The shares are held by Keith Richard Leonard, Jr. 2019 Retained Annuity Trust dated 16 Dec 2019.

Read SEC document
December 27, 2019 Filed Feb 12, 2020 17:21 UTC Unity Biotechnology, Inc. UBX · Entity 77428 GiftCommon Stock, $0.0001 par value 383,475 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-004324 · doc5.xml · nonDerivative · entry 2

Leonard Keith R · CIK 0001416180 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 0

F2 · ownership.nature: The shares were held by Andalucia Ventures LLC, a limited liability company in which the Reporting Person holds a controlling interest.

Read SEC document
December 27, 2019 Filed Feb 12, 2020 17:21 UTC Unity Biotechnology, Inc. UBX · Entity 77428 GiftCommon Stock, $0.0001 par value 116,525 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-004324 · doc5.xml · nonDerivative · entry 1

Leonard Keith R · CIK 0001416180 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,257

F1 · balance_after: Includes Restricted Stock Units which vest over time measured from the grant date.

Read SEC document
November 01, 2019 Filed Nov 7, 2019 18:42 UTC INTUITIVE SURGICAL INC ISRG · Entity 2878 GiftCommon Stock 513 $0.00 $0.00
Disclosure

SEC source: 0001035267-19-000151 · edgardoc.xml · nonDerivative · entry 1

Leonard Keith R · CIK 0001416180 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 332

F1 · kind: The filer gifted shares acquired through an RSU award granted 4/2017 to the Leonard Charitable Reminder Unit Trust (CRUT). Mr. Leonard is not an investment advisor for this trust.

Read SEC document
September 19, 2019 Filed Sep 23, 2019 20:00 UTC Unity Biotechnology, Inc. UBX · Entity 77428 GrantStock Option (Right to Buy) · Derivative 35,525 $0.00 Strike: $3.43 $0.00
Disclosure

SEC source: 0000899243-19-024073 · doc4.xml · derivative · entry 5

Leonard Keith R · CIK 0001416180 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,525

Underlying: Common Stock · 35,525 shares

Expires 2028-01-28

F5 · shares: On January 29, 2018, Reporting Person was granted an option exercisable for 142,102 shares. Twenty-five percent (25%) of the shares was subject to vesting pursuant to the achievement of a clinical development milestone; in this case proof of concept that treatment with a senolytic drug meaningfully ameliorates a human disease. On September 19, 2019, Issuer's Board of Directors determined that such milestone was achieved.

Read SEC document
June 20, 2019 Filed Jun 24, 2019 16:15 UTC Unity Biotechnology, Inc. UBX · Entity 77428 GrantStock Option (Right to Buy) · Derivative 260,000 $0.00 Strike: $9.00 $0.00
Disclosure

SEC source: 0001567619-19-013875 · doc1.xml · derivative · entry 5

Leonard Keith R · CIK 0001416180 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 260,000

Underlying: Common Stock · 260,000 shares

Expires 2029-06-19

F5 · derivative.exercise_date: The shares subject to the option vest and become exercisable in 48 successive, equal monthly installments measured from June 20, 2019, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Read SEC document
June 20, 2019 Filed Jun 24, 2019 16:15 UTC Unity Biotechnology, Inc. UBX · Entity 77428 GrantCommon Stock 40,000 $0.00 $0.00
Disclosure

SEC source: 0001567619-19-013875 · doc1.xml · nonDerivative · entry 1

Leonard Keith R · CIK 0001416180 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 210,782

F1 · shares: RSUs which vest 1/3 annually over 3 years measured from June 20, 2019.

Read SEC document
June 19, 2019 Filed Jun 19, 2019 21:14 UTC Unity Biotechnology, Inc. UBX · Entity 77428 Exercise / conversionStock Option (Right to Buy) · Derivative 20,000 $0.00 Strike: $3.40 $0.00
Disclosure

SEC source: 0001567619-19-013725 · doc1.xml · derivative · entry 5

Leonard Keith R · CIK 0001416180 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,364,100

Underlying: Common Stock · 20,000 shares

Expires 2027-01-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares subject to the option vest and become exercisable in 48 successive, equal monthly installments measured from October 26, 2016, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Read SEC document
June 19, 2019 Filed Jun 19, 2019 21:14 UTC Unity Biotechnology, Inc. UBX · Entity 77428 Exercise / conversionCommon Stock 20,000 $3.40 $68,000.00
Disclosure

SEC source: 0001567619-19-013725 · doc1.xml · nonDerivative · entry 1

Leonard Keith R · CIK 0001416180 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 170,782

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 30, 2019 Filed Jun 3, 2019 19:35 UTC Sienna Biopharmaceuticals, Inc. SNNA · Entity 154554 GrantStock Options (Right to buy) · Derivative 25,000 $0.00 Strike: $1.22 $0.00
Disclosure

SEC source: 0001562180-19-003241 · primarydocument.xml · derivative · entry 1

Leonard Keith R · CIK 0001416180 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2029-05-30

F1 · derivative.exercise_date: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, subject to continued service through each applicable vesting date.

Read SEC document
April 25, 2019 Filed Apr 26, 2019 19:36 UTC INTUITIVE SURGICAL INC ISRG · Entity 2878 GrantRestricted Stock Units · Derivative 262 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001035267-19-000064 · edgardoc.xml · derivative · entry 2

Leonard Keith R · CIK 0001416180 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 262

Underlying: Common Stock · 262 shares

Expires 2020-04-26

F2 · derivative.exercise_date: 100% of the grant will vest on the anniversary date of the grant or the next Annual Shareholders Meeting, whichever takes place first, provided however that vesting will cease on termination of the Director's service to the company.

Read SEC document
April 25, 2019 Filed Apr 26, 2019 19:36 UTC INTUITIVE SURGICAL INC ISRG · Entity 2878 GrantNon-Qualified Stock Option (right to buy) · Derivative 786 $0.00 Strike: $517.78 $0.00
Disclosure

SEC source: 0001035267-19-000064 · edgardoc.xml · derivative · entry 1

Leonard Keith R · CIK 0001416180 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 786

Underlying: Common Stock · 786 shares

Expires 2029-04-25

F1 · derivative.exercise_date: Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant or at the next Shareholders Meeting, whichever should take place first, provided that vesting will cease on termination of the Directors service to the Company.

Read SEC document
April 19, 2019 Filed Apr 23, 2019 15:51 UTC INTUITIVE SURGICAL INC ISRG · Entity 2878 Exercise / conversionRestricted Stock Units · Derivative 332 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001035267-19-000043 · edgardoc.xml · derivative · entry 2

Leonard Keith R · CIK 0001416180 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 332 shares

Expires 2022-04-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The RSUs fully vest on the earlier of the first anniversary of the date of grant or the date of the next annual stockholders meeting.

F2 · derivative.exercise_date: Restricted Stock Units (RSUs) are granted pursuant to the 2010 Incentive Award Plan. The RSUs fully vest on the first anniversary of the date of grant.

Read SEC document
April 19, 2019 Filed Apr 23, 2019 15:51 UTC INTUITIVE SURGICAL INC ISRG · Entity 2878 Exercise / conversionCommon Stock 332 $0.00 $0.00
Disclosure

SEC source: 0001035267-19-000043 · edgardoc.xml · nonDerivative · entry 1

Leonard Keith R · CIK 0001416180 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 845

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The RSUs fully vest on the earlier of the first anniversary of the date of grant or the date of the next annual stockholders meeting.

Read SEC document
February 22, 2019 Filed Feb 26, 2019 17:14 UTC Sienna Biopharmaceuticals, Inc. SNNA · Entity 154554 PurchaseCommon Stock 100,000 $2.50 $250,000.00
Disclosure

SEC source: 0001562180-19-001423 · primarydocument.xml · nonDerivative · entry 1

Leonard Keith R · CIK 0001416180 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

F1 · kind: The Reporting Person purchased the shares of the Issuer's common stock in connection with the Issuer's public offering at the offering price of $2.50 per share.

Read SEC document
June 01, 2018 Filed Jun 4, 2018 21:40 UTC Sienna Biopharmaceuticals, Inc. SNNA · Entity 154554 GrantStock Options (Right to buy) · Derivative 10,000 $0.00 Strike: $15.08 $0.00
Disclosure

SEC source: 0001562180-18-002847 · primarydocument.xml · derivative · entry 1

Leonard Keith R · CIK 0001416180 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2028-06-01

F1 · derivative.exercise_date: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, subject to continued service through each applicable vesting date.

Read SEC document
May 07, 2018 Filed May 7, 2018 18:20 UTC Unity Biotechnology, Inc. UBX · Entity 77428 ConversionSeries C Preferred Stock · Derivative 1,630 Not disclosed Not disclosed
Disclosure

SEC source: 0001140361-18-022045 · doc1.xml · derivative · entry 7

Leonard Keith R · CIK 0001416180 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,630 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's initial public offering.

F1 · price: The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's initial public offering.

F1 · derivative.exercise_date: The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's initial public offering.

F5 · derivative.expiration_date: The expiration date is not relevant to the conversion of these securities.

Read SEC document
May 07, 2018 Filed May 7, 2018 18:20 UTC Unity Biotechnology, Inc. UBX · Entity 77428 ConversionSeries B Preferred Stock · Derivative 148,448 Not disclosed Not disclosed
Disclosure

SEC source: 0001140361-18-022045 · doc1.xml · derivative · entry 6

Leonard Keith R · CIK 0001416180 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 148,448 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's initial public offering.

F1 · price: The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's initial public offering.

F1 · derivative.exercise_date: The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's initial public offering.

F5 · derivative.expiration_date: The expiration date is not relevant to the conversion of these securities.

F3 · ownership.nature: The shares are directly held by Pathfinder Investment Fund, LLC, a limited liability company in which the Reporting Person holds a controlling interest.

Read SEC document
May 07, 2018 Filed May 7, 2018 18:20 UTC Unity Biotechnology, Inc. UBX · Entity 77428 ConversionSeries B Preferred Stock · Derivative 383,475 Not disclosed Not disclosed
Disclosure

SEC source: 0001140361-18-022045 · doc1.xml · derivative · entry 5

Leonard Keith R · CIK 0001416180 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 383,475 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's initial public offering.

F1 · price: The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's initial public offering.

F1 · derivative.exercise_date: The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's initial public offering.

F5 · derivative.expiration_date: The expiration date is not relevant to the conversion of these securities.

F2 · ownership.nature: The shares are directly held by Andalucia Ventures LLC, a limited liability company in which the Reporting Person holds a controlling interest.

Read SEC document
May 07, 2018 Filed May 7, 2018 18:20 UTC Unity Biotechnology, Inc. UBX · Entity 77428 ConversionCommon Stock 1,630 Not disclosed Not disclosed
Disclosure

SEC source: 0001140361-18-022045 · doc1.xml · nonDerivative · entry 3

Leonard Keith R · CIK 0001416180 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,782

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's initial public offering.

Read SEC document
May 07, 2018 Filed May 7, 2018 18:20 UTC Unity Biotechnology, Inc. UBX · Entity 77428 ConversionCommon Stock 148,448 Not disclosed Not disclosed
Disclosure

SEC source: 0001140361-18-022045 · doc1.xml · nonDerivative · entry 2

Leonard Keith R · CIK 0001416180 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 148,448

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's initial public offering.

F3 · ownership.nature: The shares are directly held by Pathfinder Investment Fund, LLC, a limited liability company in which the Reporting Person holds a controlling interest.

Read SEC document
May 07, 2018 Filed May 7, 2018 18:20 UTC Unity Biotechnology, Inc. UBX · Entity 77428 ConversionCommon Stock 383,475 Not disclosed Not disclosed
Disclosure

SEC source: 0001140361-18-022045 · doc1.xml · nonDerivative · entry 1

Leonard Keith R · CIK 0001416180 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 383,475

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's initial public offering.

F2 · ownership.nature: The shares are directly held by Andalucia Ventures LLC, a limited liability company in which the Reporting Person holds a controlling interest.

Read SEC document
May 02, 2018 Filed May 4, 2018 18:21 UTC Unity Biotechnology, Inc. UBX · Entity 77428 GrantStock Option (Right to Buy) · Derivative 67,797 $0.00 Strike: $17.00 $0.00
Disclosure

SEC source: 0001140361-18-021813 · doc1.xml · derivative · entry 1

Leonard Keith R · CIK 0001416180 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,797

Underlying: Common Stock · 67,797 shares

Expires 2028-05-01

F1 · derivative.exercise_date: The shares subject to the option vest as to 25% of the shares on the one-year anniversary of May 2, 2018, and 1/48th of the shares shall vest on each monthly anniversary thereafter, subject to the optionee remainining a service provider to the Issuer on each such vesting date.

Read SEC document
April 19, 2018 Filed Apr 20, 2018 00:18 UTC INTUITIVE SURGICAL INC ISRG · Entity 2878 GrantRestricted Stock Units · Derivative 332 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001035267-18-000053 · edgardoc.xml · derivative · entry 4

Leonard Keith R · CIK 0001416180 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 332

Underlying: Common Stock · 332 shares

Expires 2022-04-19

F4 · derivative.exercise_date: Restricted Stock Units (RSUs) are granted pursuant to the 2010 Incentive Award Plan. The RSUs fully vest on the first anniversary of the date of grant.

Read SEC document
April 19, 2018 Filed Apr 20, 2018 00:18 UTC INTUITIVE SURGICAL INC ISRG · Entity 2878 Exercise / conversionRestricted Stock Units · Derivative 513 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001035267-18-000053 · edgardoc.xml · derivative · entry 3

Leonard Keith R · CIK 0001416180 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 513 shares

Expires 2018-02-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 100% of the grant will vest on the anniversary date of the grant or the next Annual Shareholders Meeting, whichever takes place first, provided however that vesting will cease on termination of the Director's service to the company.

Read SEC document
April 19, 2018 Filed Apr 20, 2018 00:18 UTC INTUITIVE SURGICAL INC ISRG · Entity 2878 GrantNon-Qualified Stock Option (right to buy) · Derivative 996 $0.00 Strike: $462.71 $0.00
Disclosure

SEC source: 0001035267-18-000053 · edgardoc.xml · derivative · entry 2

Leonard Keith R · CIK 0001416180 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 996

Underlying: Common Stock · 996 shares

Expires 2028-04-19

F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant or at the next Shareholders Meeting, whichever should take place first, provided that vesting will cease on termination of the Directors service to the Company.

Read SEC document
April 19, 2018 Filed Apr 20, 2018 00:18 UTC INTUITIVE SURGICAL INC ISRG · Entity 2878 Exercise / conversionCommon Stock 513 $0.00 $0.00
Disclosure

SEC source: 0001035267-18-000053 · edgardoc.xml · nonDerivative · entry 1

Leonard Keith R · CIK 0001416180 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 513

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were acquired from the vest and release of an RSU grant previously issued to the Filer.

Read SEC document
November 01, 2017 Filed Nov 2, 2017 11:51 UTC Sienna Biopharmaceuticals, Inc. SNNA · Entity 154554 GrantStock Option (Right to Buy) · Derivative 5,315 $0.00 Strike: $19.91 $0.00
Disclosure

SEC source: 0001140361-17-040668 · doc1.xml · derivative · entry 1

Leonard Keith R · CIK 0001416180 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,315

Underlying: Common Stock · 5,315 shares

Expires 2027-11-01

F1 · derivative.exercise_date: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, subject to continued service through each applicable vesting date.

Read SEC document
August 31, 2017 Filed Sep 1, 2017 15:27 UTC INTUITIVE SURGICAL INC ISRG · Entity 2878 Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 327 $0.00 Strike: $641.91 $0.00
Disclosure

SEC source: 0001035267-17-000131 · edgardoc.xml · derivative · entry 7

Leonard Keith R · CIK 0001416180 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 327 shares

Expires 2026-04-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Options will vest 100% on the earlier of the first anniversary of the date of grant or the date of the next annual stockholders meeting.

Read SEC document
August 31, 2017 Filed Sep 1, 2017 15:27 UTC INTUITIVE SURGICAL INC ISRG · Entity 2878 Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 100 $0.00 Strike: $526.59 $0.00
Disclosure

SEC source: 0001035267-17-000131 · edgardoc.xml · derivative · entry 6

Leonard Keith R · CIK 0001416180 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 100 shares

Expires 2026-01-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant or at the next Shareholders Meeting, whichever should take place first, provided that vesting will cease on termination of the Directors service to the Company.

Read SEC document
August 31, 2017 Filed Sep 1, 2017 15:27 UTC INTUITIVE SURGICAL INC ISRG · Entity 2878 SaleCommon Stock 427 $1,000.00 $427,000.00
Disclosure

SEC source: 0001035267-17-000131 · edgardoc.xml · nonDerivative · entry 5

Leonard Keith R · CIK 0001416180 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: These shares were sold pursuant to a 10b5-1 Trading Plan entered into on January 27, 2017.

Read SEC document
August 31, 2017 Filed Sep 1, 2017 15:27 UTC INTUITIVE SURGICAL INC ISRG · Entity 2878 SaleCommon Stock 100 $1,000.00 $100,000.00
Disclosure

SEC source: 0001035267-17-000131 · edgardoc.xml · nonDerivative · entry 4

Leonard Keith R · CIK 0001416180 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 427

F1 · kind: These shares were sold pursuant to a 10b5-1 Trading Plan entered into on January 27, 2017.

Read SEC document
August 31, 2017 Filed Sep 1, 2017 15:27 UTC INTUITIVE SURGICAL INC ISRG · Entity 2878 Exercise / conversionCommon Stock 100 $526.59 $52,659.00
Disclosure

SEC source: 0001035267-17-000131 · edgardoc.xml · nonDerivative · entry 3

Leonard Keith R · CIK 0001416180 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 527

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 31, 2017 Filed Sep 1, 2017 15:27 UTC INTUITIVE SURGICAL INC ISRG · Entity 2878 SaleCommon Stock 327 $1,000.00 $327,000.00
Disclosure

SEC source: 0001035267-17-000131 · edgardoc.xml · nonDerivative · entry 2

Leonard Keith R · CIK 0001416180 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 427

F1 · kind: These shares were sold pursuant to a 10b5-1 Trading Plan entered into on January 27, 2017.

Read SEC document
August 31, 2017 Filed Sep 1, 2017 15:27 UTC INTUITIVE SURGICAL INC ISRG · Entity 2878 Exercise / conversionCommon Stock 327 $641.91 $209,904.57
Disclosure

SEC source: 0001035267-17-000131 · edgardoc.xml · nonDerivative · entry 1

Leonard Keith R · CIK 0001416180 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 754

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 01, 2017 Filed Aug 1, 2017 16:22 UTC Sienna Biopharmaceuticals, Inc. SNNA · Entity 154554 ConversionSeries A-3 Preferred Stock · Derivative 31,784 Not disclosed Not disclosed
Disclosure

SEC source: 0001140361-17-029593 · doc1.xml · derivative · entry 3

Leonard Keith R · CIK 0001416180 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 31,784 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's initial public offering.

F1 · price: The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's initial public offering.

F1 · derivative.exercise_date: The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's initial public offering.

F5 · derivative.expiration_date: The expiration date is not relevant to the conversion of these securities.

F2 · ownership.nature: The shares are directly held by Andalucia Ventures LLC, a limited liability company in which the Reporting Person holds a controlling interest.

Read SEC document
August 01, 2017 Filed Aug 1, 2017 16:22 UTC Sienna Biopharmaceuticals, Inc. SNNA · Entity 154554 PurchaseCommon Stock 16,700 $15.00 $250,500.00
Disclosure

SEC source: 0001140361-17-029593 · doc1.xml · nonDerivative · entry 2

Leonard Keith R · CIK 0001416180 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 16,700

F3 · kind: The Reporting Person purchased the shares of the Issuer's common stock in connection with the Issuer's initial public offering at the offering price of $15.00 per share.

F4 · ownership.nature: The shares are directly held by the Leonard Family Trust.

Read SEC document
August 01, 2017 Filed Aug 1, 2017 16:22 UTC Sienna Biopharmaceuticals, Inc. SNNA · Entity 154554 ConversionCommon Stock 31,784 Not disclosed Not disclosed
Disclosure

SEC source: 0001140361-17-029593 · doc1.xml · nonDerivative · entry 1

Leonard Keith R · CIK 0001416180 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 31,784

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's initial public offering.

F2 · ownership.nature: The shares are directly held by Andalucia Ventures LLC, a limited liability company in which the Reporting Person holds a controlling interest.

Read SEC document
April 20, 2017 Filed Apr 21, 2017 21:25 UTC INTUITIVE SURGICAL INC ISRG · Entity 2878 Exercise / conversionRestricted Stock Units · Derivative 327 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001035267-17-000065 · edgardoc.xml · derivative · entry 4

Leonard Keith R · CIK 0001416180 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 327 shares

Expires 2020-04-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 100% of the grant will vest on the anniversary date of the grant or the next Annual Shareholders Meeting, whichever takes place first, provided however that vesting will cease on termination of the Director's service to the company.

Read SEC document
April 20, 2017 Filed Apr 21, 2017 21:25 UTC INTUITIVE SURGICAL INC ISRG · Entity 2878 GrantRestricted Stock Units · Derivative 171 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001035267-17-000065 · edgardoc.xml · derivative · entry 3

Leonard Keith R · CIK 0001416180 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 171

Underlying: Common Stock · 171 shares

Expires 2018-02-21

F3 · derivative.exercise_date: 100% of the grant will vest on the anniversary date of the grant or the next Annual Shareholders Meeting, whichever takes place first, provided however that vesting will cease on termination of the Director's service to the company.

Read SEC document
April 20, 2017 Filed Apr 21, 2017 21:25 UTC INTUITIVE SURGICAL INC ISRG · Entity 2878 GrantNon-Qualified Stock Option (right to buy) · Derivative 515 $0.00 Strike: $814.45 $0.00
Disclosure

SEC source: 0001035267-17-000065 · edgardoc.xml · derivative · entry 2

Leonard Keith R · CIK 0001416180 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 515

Underlying: Common Stock · 515 shares

Expires 2027-04-20

F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant or at the next Shareholders Meeting, whichever should take place first, provided that vesting will cease on termination of the Directors service to the Company.

Read SEC document
April 20, 2017 Filed Apr 21, 2017 21:25 UTC INTUITIVE SURGICAL INC ISRG · Entity 2878 Exercise / conversionCommon Stock 327 $0.00 $0.00
Disclosure

SEC source: 0001035267-17-000065 · edgardoc.xml · nonDerivative · entry 1

Leonard Keith R · CIK 0001416180 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 427

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: These shares were acquired from the vest and release of an RSU grant previously issued to the Filer.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.